Royal Bank Of Canada Aziyo Biologics, Inc. Transaction History

Royal Bank Of Canada

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	N/A	-36 Reduced 15.06%	203 $0
Q1 2024 Nov 05, 2024	BUY	N/A	36 Added 17.73%	239 $0
Q1 2024 May 15, 2024	BUY	N/A	129 Added 117.27%	239 $0
Q4 2023 Feb 14, 2024	BUY	$1.14 - $1.45 $2 - $2	2 Added 1.85%	110 $0
Q2 2023 Aug 14, 2023	BUY	$1.41 - $2.79 $152 - $301	108 New	108 $0
Q3 2022 Nov 14, 2022	BUY	$5.72 - $7.76 $194 - $263	34 New	34 $0
Q3 2021 Nov 15, 2021	SELL	$6.75 - $9.52 $222 - $314	-33 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$9.51 - $13.97 $313 - $461	33 New	33 $0

12.2M

Ticker AZYO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 9,308,720
Market Cap $13.5M
Description
Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of inf...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.